Modulatory potential of iron chelation therapy on nitric oxide formation in cerebral malaria. 1997

G Weiss, and P E Thuma, and G Mabeza, and E R Werner, and M Herold, and V R Gordeuk
Department of Internal Medicine, University Hospital, University of Innsbruck, Austria.

To determine whether iron chelation modulates nitric oxide (NO) formation and cell-mediated immune effector function in children with cerebral malaria, serum concentrations were measured of the stable end products of NO, nitrite and nitrate (NO2-/NO3-), interleukin (IL)-4, -6, and -10, and neopterin in 39 Zambian children enrolled in a placebo-controlled trial of desferrioxamine B and quinine therapy. Mean concentrations of NO2-/NO3- increased significantly over 3 days in children receiving desferrioxamine plus quinine but not in those given placebo and quinine. Neopterin levels declined significantly with placebo but not with desferrioxamine. IL-4 levels increased progressively in the placebo group and ultimately decreased in the desferrioxamine group, but the trends were not statistically significant. IL-6 and IL-10 levels were elevated initially and decreased significantly in both groups over 3 days. These data are consistent with the hypothesis that iron chelation therapy in children with cerebral malaria strengthens Th1-mediated immune effector function involving increased production of NO.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007378 Interleukins Soluble factors which stimulate growth-related activities of leukocytes as well as other cell types. They enhance cell proliferation and differentiation, DNA synthesis, secretion of other biologically active molecules and responses to immune and inflammatory stimuli. Interleukin
D007501 Iron A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN. Iron-56,Iron 56
D009566 Nitrates Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical. Nitrate
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D009573 Nitrites Salts of nitrous acid or compounds containing the group NO2-. The inorganic nitrites of the type MNO2 (where M Nitrite
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003676 Deferoxamine Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form. Desferrioxamine,Deferoxamine B,Deferoxamine Mesilate,Deferoxamine Mesylate,Deferoxamine Methanesulfonate,Deferoximine,Deferrioxamine B,Desferal,Desferioximine,Desferrioxamine B,Desferrioxamine B Mesylate,Desferroxamine,Mesilate, Deferoxamine,Mesylate, Deferoxamine,Mesylate, Desferrioxamine B,Methanesulfonate, Deferoxamine
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked

Related Publications

G Weiss, and P E Thuma, and G Mabeza, and E R Werner, and M Herold, and V R Gordeuk
January 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene,
G Weiss, and P E Thuma, and G Mabeza, and E R Werner, and M Herold, and V R Gordeuk
January 1994, Advances in experimental medicine and biology,
G Weiss, and P E Thuma, and G Mabeza, and E R Werner, and M Herold, and V R Gordeuk
April 1995, The Journal of infectious diseases,
G Weiss, and P E Thuma, and G Mabeza, and E R Werner, and M Herold, and V R Gordeuk
June 1994, The Journal of infectious diseases,
G Weiss, and P E Thuma, and G Mabeza, and E R Werner, and M Herold, and V R Gordeuk
November 1992, The New England journal of medicine,
G Weiss, and P E Thuma, and G Mabeza, and E R Werner, and M Herold, and V R Gordeuk
March 1993, Lancet (London, England),
G Weiss, and P E Thuma, and G Mabeza, and E R Werner, and M Herold, and V R Gordeuk
January 1992, Lancet (London, England),
G Weiss, and P E Thuma, and G Mabeza, and E R Werner, and M Herold, and V R Gordeuk
January 1999, Pharmacology & therapeutics,
G Weiss, and P E Thuma, and G Mabeza, and E R Werner, and M Herold, and V R Gordeuk
January 1995, Medecine tropicale : revue du Corps de sante colonial,
G Weiss, and P E Thuma, and G Mabeza, and E R Werner, and M Herold, and V R Gordeuk
January 1996, Romanian journal of physiology : physiological sciences,
Copied contents to your clipboard!